Bill Commons

NM HB 83

dead

PERSONAL CARE SERVICES MEDICAID REIMBURSEMENT

New Mexico · 2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did NM HB 83 pass?

No. NM HB 83 did not pass — it was defeated or died in the legislative process. Latest recorded action (2026-03-24): action postponed indefinitely

What is NM HB 83 about?

NM HB 83 is a bill in the 2026 Regular Session titled “PERSONAL CARE SERVICES MEDICAID REIMBURSEMENT”.

Who sponsors NM HB 83?

Armstrong, Gail, Hernandez, Joseph Franklin, Duncan, Mark and 2 others are the primary sponsors of NM HB 83.

Introduced
2026-01-15
Latest action
2026-03-24 — action postponed indefinitely
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Armstrong, Gailprimary
  • Hernandez, Joseph Franklinprimary
  • Duncan, Markprimary
  • Sanchez, Josephprimary
  • Dow, Rebeccaprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-03-24

    action postponed indefinitely

  2. 2026-01-22

    not printed House Rules and Order of Business Committee

  3. 2026-01-15

    Sent to House Pre-file

    introduction,referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:06.602582Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NM&identifier=HB 83. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.